Table of Contents

2019-2024 Global Cefprozil Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Cefprozil Consumption 2014-2024
  • 2.1.2 Cefprozil Consumption CAGR by Region
• 2.2 Cefprozil Segment by Type
  • 2.2.1 Anhydrous
  • 2.2.2 Monohydrate
• 2.3 Cefprozil Consumption by Type
  • 2.3.1 Global Cefprozil Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Cefprozil Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Cefprozil Sale Price by Type (2014-2019)
• 2.4 Cefprozil Segment by Application
  • 2.4.1 Pharyngitis/tonsillitis
  • 2.4.2 Otitis Media
  • 2.4.3 Acute Sinusitis
  • 2.4.4 Secondary Bacterial Infection
  • 2.4.5 Uncomplicated Skin
  • 2.4.6 Other
• 2.5 Cefprozil Consumption by Application
  • 2.5.1 Global Cefprozil Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Cefprozil Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Cefprozil Sale Price by Application (2014-2019)

3 Global Cefprozil by Players

• 3.1 Global Cefprozil Sales Market Share by Players
  • 3.1.1 Global Cefprozil Sales by Players (2017-2019)
  • 3.1.2 Global Cefprozil Sales Market Share by Players (2017-2019)
• 3.2 Global Cefprozil Revenue Market Share by Players
  • 3.2.1 Global Cefprozil Revenue by Players (2017-2019)
  • 3.2.2 Global Cefprozil Revenue Market Share by Players (2017-2019)
• 3.3 Global Cefprozil Sale Price by Players
• 3.4 Global Cefprozil Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Cefprozil Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Cefprozil Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Cefprozil by Regions

• 4.1 Cefprozil by Regions
  • 4.1.1 Global Cefprozil Consumption by Regions
  • 4.1.2 Global Cefprozil Value by Regions
• 4.2 Americas Cefprozil Consumption Growth
• 4.3 APAC Cefprozil Consumption Growth
• 4.4 Europe Cefprozil Consumption Growth
• 4.5 Middle East & Africa Cefprozil Consumption Growth

5 Americas

• 5.1 Americas Cefprozil Consumption by Countries
  • 5.1.1 Americas Cefprozil Consumption by Countries (2014-2019)
  • 5.1.2 Americas Cefprozil Value by Countries (2014-2019)
• 5.2 Americas Cefprozil Consumption by Type
• 5.3 Americas Cefprozil Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Cefprozil Consumption by Countries
  • 6.1.1 APAC Cefprozil Consumption by Countries (2014-2019)
  • 6.1.2 APAC Cefprozil Value by Countries (2014-2019)
• 6.2 APAC Cefprozil Consumption by Type
• 6.3 APAC Cefprozil Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Cefprozil by Countries
  • 7.1.1 Europe Cefprozil Consumption by Countries (2014-2019)
  • 7.1.2 Europe Cefprozil Value by Countries (2014-2019)
• 7.2 Europe Cefprozil Consumption by Type
• 7.3 Europe Cefprozil Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Cefprozil by Countries
  • 8.1.1 Middle East & Africa Cefprozil Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Cefprozil Value by Countries (2014-2019)
• 8.2 Middle East & Africa Cefprozil Consumption by Type
• 8.3 Middle East & Africa Cefprozil Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Cefprozil Distributors
• 10.3 Cefprozil Customer

11 Global Cefprozil Market Forecast

• 11.1 Global Cefprozil Consumption Forecast (2019-2024)
• 11.2 Global Cefprozil Forecast by Regions
  • 11.2.1 Global Cefprozil Forecast by Regions (2019-2024)
  • 11.2.2 Global Cefprozil Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Cefprozil Forecast by Type
• 11.8 Global Cefprozil Forecast by Application

12 Key Players Analysis

• 12.1 Orchid
  • 12.1.1 Company Details
  • 12.1.2 Cefprozil Product Offered
  • 12.1.3 Orchid Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Orchid News
• 12.2 Taj Pharma
  • 12.2.1 Company Details
  • 12.2.2 Cefprozil Product Offered
  • 12.2.3 Taj Pharma Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Taj Pharma News
• 12.3 Dhanuka
  • 12.3.1 Company Details
  • 12.3.2 Cefprozil Product Offered
  • 12.3.3 Dhanuka Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Dhanuka News
• 12.4 Lupin
  • 12.4.1 Company Details
  • 12.4.2 Cefprozil Product Offered
  • 12.4.3 Lupin Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Lupin News
• 12.5 Alkem
  • 12.5.1 Company Details
  • 12.5.2 Cefprozil Product Offered
  • 12.5.3 Alkem Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Alkem News
• 12.6 Corden Pharma
  • 12.6.1 Company Details
  • 12.6.2 Cefprozil Product Offered
  • 12.6.3 Corden Pharma Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Corden Pharma News
• 12.7 Aurobindo
  • 12.7.1 Company Details
  • 12.7.2 Cefprozil Product Offered
  • 12.7.3 Aurobindo Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Aurobindo News
• 12.8 Covalent
  • 12.8.1 Company Details
  • 12.8.2 Cefprozil Product Offered
  • 12.8.3 Covalent Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Covalent News
• 12.9 TEVA GROUP
  • 12.9.1 Company Details
  • 12.9.2 Cefprozil Product Offered
  • 12.9.3 TEVA GROUP Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 TEVA GROUP News
• 12.10 Hetero Drugs
  • 12.10.1 Company Details
  • 12.10.2 Cefprozil Product Offered
  • 12.10.3 Hetero Drugs Cefprozil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Hetero Drugs News
• 12.11 Qilu Antibiotics
• 12.12 Dongying Pharma
• 12.13 Union Chempharma
• 12.14 Huafangpharm
• 12.15 Topfond

13 Research Findings and Conclusion

Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Due to the manufacture policy, the Cefprozil industry is relative concentrated, the manufacture technology is relative mature.
India and China are the main production areas, India with a market share of 50.79%, China with a market share of 29.03%, China Most of the products are exported to developed countries.

According to this study, over the next five years the Cefprozil market will register a 0.8% CAGR in terms of revenue, the global market size will reach US$ 140 million by 2024, from US$ 130 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cefprozil business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cefprozil market by product type, application, key manufacturers and key regions and countries.

This study considers the Cefprozil value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anhydrous
Monohydrate
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pharyngitis/tonsillitis
Otitis Media
Acute Sinusitis
Secondary Bacterial Infection
Uncomplicated Skin
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Orchid
Taj Pharma
Dhanuka
Lupin
Alkem
Corden Pharma
Aurobindo
Covalent
TEVA GROUP
Hetero Drugs
Qilu Antibiotics
Dongying Pharma
Union Chempharma
Huafangpharm
Topfond

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Cefprozil consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cefprozil market by identifying its various subsegments.
Focuses on the key global Cefprozil manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cefprozil with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cefprozil submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.